Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7093)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2020 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yi PS, Wang H, Li JS. Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(3): 85-92 [PMID: 32218891 DOI: 10.4240/wjgs.v12.i3.85] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v12/i3/85.htm |
| Number | Citing Articles |
| 1 |
Jie Zan, Xuya Zhao, Xiya Deng, Hongda Ding, Bi Wang, Minyi Lu, Zijing Wei, Zhi Huang, Shuai Wang. Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(2): 465 doi: 10.1016/j.jcmgh.2021.02.010
|
| 2 |
Li Li, Anqi Chen, Bingmi Liu, Hao Pan, Yanjie Yu, Yu Liu. Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery. Biomedical Materials 2022; 17(4): 045006 doi: 10.1088/1748-605X/ac6b73
|
| 3 |
Yuehui Liang, Qi Liang, Liang Qiao, Fang Xiao. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00920
|
| 4 |
Masateru Yamamoto, Tsuyoshi Kobayashi, Masakazu Hashimoto, Shintaro Kuroda, Tomokazu Kawaoka, Hiroshi Aikata, Kazuaki Chayama, Hideki Ohdan. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08421-3
|
| 5 |
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current Oncology 2024; 31(1): 547 doi: 10.3390/curroncol31010038
|
| 6 |
Hee Ho Chu, Jin Hyoung Kim, Ju Hyun Shim, Dong Il Gwon, Heung-Kyu Ko, Ji Hoon Shin, Gi-Young Ko, Hyun-Ki Yoon, Nayoung Kim. Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 2021; 13(11): 2830 doi: 10.3390/cancers13112830
|
| 7 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
| 8 |
Junning Liu, Shu Yan, Guangnian Zhang, Linfeng Yang, Song Wei, Pengsheng Yi. A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma. Oncology Letters 2023; 26(6) doi: 10.3892/ol.2023.14094
|
| 9 |
Henrique A. Lima, Yutaka Endo, Laura Alaimo, Zorays Moazzam, Muhammad Musaab Munir, Chanza Shaikh, Vivian Resende, Alfredo Guglielmi, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Tom Hugh, Itaru Endo, Minoru Kitago, Feng Shen, Timothy M. Pawlik. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2022; 26(12): 2512 doi: 10.1007/s11605-022-05469-9
|